Inflammatory cells and airway remodelling in COPD

X. Yao (Nanjing (Jiangsu), China)

Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
X. Yao (Nanjing (Jiangsu), China). Inflammatory cells and airway remodelling in COPD. International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inflammatory cells and airway remodelling in COPD: clinical implications
Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Year: 2019


Bronchial wall inflammatory cells and signs of remodeling in COPD and asthma
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019

Airway inflammatory mediators and airway wall remodelling in asthma
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009



Airway inflammation markers in COPD
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I
Year: 2007


Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis
Source: Eur Respir J 2012; 39: 1361-1367
Year: 2012



Allergen-induced airway remodelling
Source: Eur Respir J 2007; 29: 1020-1032
Year: 2007



Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007



Pulmonary vascular remodelling in COPD versus bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 82s
Year: 2003

Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018




Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008

Inflammatory cell phenotypes in bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 484s
Year: 2005

Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003



Increased arginase activity contributes to airway remodelling in chronic allergic asthma
Source: Eur Respir J 2011; 38: 318-328
Year: 2011



Eicosanoids and eosinophilic inflammation of airways in stable COPD.
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018


Airway remodelling in asthma is related to particular characteristics of airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 188s
Year: 2002

The role of small airways in obstructive airway diseases
Source: Eur Respir Rev 2011; 20: 23-33
Year: 2011



Novel concepts in airway inflammation and remodelling in asthma
Source: Eur Respir J 2015; 46: 1796-1804
Year: 2015